Medmo

High-Level Overview

Medmo is a healthcare technology startup that provides an AI-powered platform for providers to order, schedule, and track medical imaging appointments like MRIs, CT scans, and PET scans.[2][4] It serves ordering providers across specialties, including orthopedics, in all 50 states, solving inefficiencies in imaging referrals such as delayed appointments, low adherence rates, high administrative costs, and exams in expensive settings by guiding patients to high-value in-network centers, boosting completion rates, and closing the care loop with real-time updates.[2][4] Medmo has raised $15 million in a Series A round and previously $9 million in funding, demonstrating strong growth momentum with partnerships like Sorin Medical and claims of 30% higher patient adherence and 95% reduced staff time on referrals for clients.[1][4][5]

Origin Story

Medmo was founded in 2017 and incorporated on October 27, 2017, in New York City, with Dr. Christopher Kelly MD as CEO and Lucas Takahashi as co-founder.[3] Operating from 122 Grand Street in Chinatown, NY, the company emerged to address patient pain points in medical imaging—long waits, unnecessary travel, and high costs—while easing administrative burdens for providers and optimizing capacity for imaging centers.[3][5] Early traction included BBB accreditation in 2019 and funding rounds, with a $9 million raise led by Lerer Hippeau alongside Jerusalem Venture Partners (JVP), C2 Ventures, Stone IsraVentures, and angels, followed by a $15 million Series A to fuel expansion.[1][5]

Core Differentiators

• Comprehensive Workflow: All-encompassing solution handling ordering, scheduling, patient navigation to high-value centers, care team support, and result sharing across modalities, insurance types, and locations in all 50 states.[2][4]
• Proven Outcomes: Increases patient adherence by 30%, cuts staff referral time by 95%, reduces costs via in-network routing, and improves HEDIS/Star ratings with faster turnaround and higher completion rates.[2][4]
• Patient-Centric Ease: Real-time updates, direct support as first line for inquiries, and guidance to affordable, high-quality care, benefiting both brick-and-mortar and virtual providers.[2][4]
• Provider Control: Regains oversight of patient panels, ensures follow-up care loop closure, and minimizes low-value encounters.[2]

Role in the Broader Tech Landscape

Medmo rides the value-based care trend in healthcare, where reducing costs and improving outcomes amid rising imaging expenses aligns with payer pressures and regulations like HEDIS/Star ratings.[2][4] Its timing capitalizes on post-pandemic diagnostic backlogs, AI-driven coordination needs, and a fragmented $100+ billion U.S. imaging market strained by administrative inefficiencies.[4][5] Market forces favoring Medmo include health system consolidation, insurer demands for in-network utilization, and tech adoption by 60%+ of U.S. systems via platforms like Elion, positioning it to influence ecosystems by streamlining referrals and boosting adherence across providers.[2]

Quick Take & Future Outlook

Medmo's platform positions it for scaled adoption as AI care coordination matures, with next steps likely expanding enterprise partnerships, enhancing AI for predictive scheduling, and entering adjacent diagnostics amid value-based shifts.[4][5] Trends like telehealth integration and payer-provider alignments will amplify its efficiencies, potentially evolving its influence from niche imaging optimizer to broader diagnostic orchestrator, tying back to its core mission of making high-quality care accessible and seamless for patients and providers.[2][4]